File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Doses of radiation to the pericardium, instead of heart, are significant for survival in patients with non-small cell lung cancer

TitleDoses of radiation to the pericardium, instead of heart, are significant for survival in patients with non-small cell lung cancer
Authors
KeywordsHeart dose
NSCLC
Pericardial dose
Pericardial effusion
Issue Date2018
Citation
Radiotherapy and Oncology, 2018 How to Cite?
Abstract© 2018 Elsevier B.V. Background and purpose: Higher cardiac dose was associated with worse overall survival in the RTOG0617 study. Pericardial effusion (PCE) is a common cardiac complication of thoracic radiation therapy (RT). We investigated whether doses of radiation to the heart and pericardium are associated with PCE and overall survival in patients treated with thoracic radiation for non-small cell lung cancer (NSCLC). Materials and methods: A total of 94 patients with medically inoperable/unresectable NSCLC treated with definitive RT in prospective studies were reviewed for this secondary analysis. Heart and pericardium were contoured consistently according to the RTOG1106 Atlas, with the great vessels and thymus of the upper mediastinal structures included in the upper part of pericardium, only heart chambers included in the heart structure. Clinical factors and dose–volume parameters associated with PCE or survival were identified via Cox proportional hazards modeling. The risk of PCE and death were mapped using DVH atlases. Results: Median follow-up for surviving patients was 58 months. The overall rate of PCE was 40.4%. On multivariable analysis, dosimetric factors of heart and pericardium were significantly associated with the risk of PCE. Pericardial V30 and V55 were significantly correlated with overall survival, but presence of PCE and heart dosimetric factors were not. Conclusion: PCE was associated with both heart and pericardial doses. The significance of pericardial dosimetric parameters, but not heart chamber parameters, on survival suggests the potential significance of radiation damage to the cranial region of pericardium.
Persistent Identifierhttp://hdl.handle.net/10722/266854
ISSN
2020 Impact Factor: 6.28
2020 SCImago Journal Rankings: 1.892
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorXue, Jianxin-
dc.contributor.authorHan, Chengbo-
dc.contributor.authorJackson, Andrew-
dc.contributor.authorHu, Chen-
dc.contributor.authorYao, Huan-
dc.contributor.authorWang, Weili-
dc.contributor.authorHayman, James-
dc.contributor.authorChen, Weijun-
dc.contributor.authorJin, Jianyue-
dc.contributor.authorKalemkerian, Gregory P.-
dc.contributor.authorMatuzsak, Martha-
dc.contributor.authorJolly, Struti-
dc.contributor.authorKong, Feng Ming (Spring)-
dc.date.accessioned2019-01-31T07:19:48Z-
dc.date.available2019-01-31T07:19:48Z-
dc.date.issued2018-
dc.identifier.citationRadiotherapy and Oncology, 2018-
dc.identifier.issn0167-8140-
dc.identifier.urihttp://hdl.handle.net/10722/266854-
dc.description.abstract© 2018 Elsevier B.V. Background and purpose: Higher cardiac dose was associated with worse overall survival in the RTOG0617 study. Pericardial effusion (PCE) is a common cardiac complication of thoracic radiation therapy (RT). We investigated whether doses of radiation to the heart and pericardium are associated with PCE and overall survival in patients treated with thoracic radiation for non-small cell lung cancer (NSCLC). Materials and methods: A total of 94 patients with medically inoperable/unresectable NSCLC treated with definitive RT in prospective studies were reviewed for this secondary analysis. Heart and pericardium were contoured consistently according to the RTOG1106 Atlas, with the great vessels and thymus of the upper mediastinal structures included in the upper part of pericardium, only heart chambers included in the heart structure. Clinical factors and dose–volume parameters associated with PCE or survival were identified via Cox proportional hazards modeling. The risk of PCE and death were mapped using DVH atlases. Results: Median follow-up for surviving patients was 58 months. The overall rate of PCE was 40.4%. On multivariable analysis, dosimetric factors of heart and pericardium were significantly associated with the risk of PCE. Pericardial V30 and V55 were significantly correlated with overall survival, but presence of PCE and heart dosimetric factors were not. Conclusion: PCE was associated with both heart and pericardial doses. The significance of pericardial dosimetric parameters, but not heart chamber parameters, on survival suggests the potential significance of radiation damage to the cranial region of pericardium.-
dc.languageeng-
dc.relation.ispartofRadiotherapy and Oncology-
dc.subjectHeart dose-
dc.subjectNSCLC-
dc.subjectPericardial dose-
dc.subjectPericardial effusion-
dc.titleDoses of radiation to the pericardium, instead of heart, are significant for survival in patients with non-small cell lung cancer-
dc.typeArticle-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1016/j.radonc.2018.10.029-
dc.identifier.scopuseid_2-s2.0-85056222962-
dc.identifier.spagenull-
dc.identifier.epagenull-
dc.identifier.eissn1879-0887-
dc.identifier.isiWOS:000462762200031-
dc.identifier.issnl0167-8140-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats